1-8 of 8
Authors: Marta Padovan
Journal Article
EPCO-22. LONGITUDINAL MOLECULAR CHARACTERIZATION IDENTIFIES TREATMENT DRIVEN EVOLUTION OF OLIGODENDROGLIOMA Free
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v128, https://doi.org/10.1093/neuonc/noad179.0485
Published: 10 November 2023
Journal Article
CTNI-15. REGORAFENIB IN COMBINATION WITH TEMOZOLOMIDE WITH OR WITHOUT RADIOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED MGMT-METHYLATED, IDH WILDTYPE GLIOBLASTOMA: A PHASE I DOSE-FINDING STUDY (REGOMA-2) Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii73, https://doi.org/10.1093/neuonc/noac209.281
Published: 14 November 2022
Journal Article
PATH-11. THE LONGITUDINAL EVOLUTIONARY TRAJECTORY OF OLIGODENDROGLIOMA IS DRIVEN BY TREATMENT-ASSOCIATED GENETIC ALTERATIONS Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii152, https://doi.org/10.1093/neuonc/noac209.584
Published: 14 November 2022
Journal Article
ANGI-09. BEVACIZUMAB IN ATYPICAL AND ANAPLASTIC MENINGIOMAS: THE BEMEN STUDY Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii3, https://doi.org/10.1093/neuonc/noac209.008
Published: 14 November 2022
Journal Article
BIOM-19. NEXT-GENERATION SEQUENCING (NGS) FOR IDENTIFYING ACTIONABLE MOLECULAR ALTERATIONS IN NEWLY DIAGNOSED AND RECURRENT IDHWT-GLIOBLASTOMA (GBM) PATIENTS: A LARGE MONO INSTITUTIONAL EXPERIENCE Free
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii8, https://doi.org/10.1093/neuonc/noac209.029
Published: 14 November 2022
Journal Article
CTNI-12. PHASE II MULTICENTRIC ITALIAN TRIAL ON REPOSITIONING OF THE ANTIPSYCHOTIC DRUG CHLORPROMAZINE AND ITS SYNERGISM WITH TEMOZOLOMIDE IN MGMT UNMETHYLATED GLIOBLASTOMA PATIENTS: THE RACTAC TRIAL Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi61, https://doi.org/10.1093/neuonc/noab196.237
Published: 12 November 2021
Journal Article
CTNI-50. REGORAFENIB IN RECURRENT GLIOBLASTOMA PATIENTS: A LARGE REAL-LIFE EXPERIENCE Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Page vi71, https://doi.org/10.1093/neuonc/noab196.275
Published: 12 November 2021
Journal Article
CTNI-33. METRONOMIC TEMOZOLOMIDE THERAPY IN HEAVILY PRETREATED PATIENTS WITH RECURRENT GLIOBLASTOMA: A LARGE MONO-INSTITUTIONAL RETROSPECTIVE STUDY Free
Neuro-Oncology, Volume 23, Issue Supplement_6, November 2021, Pages vi66–vi67, https://doi.org/10.1093/neuonc/noab196.258
Published: 12 November 2021
